Search research articles
Contact Us
Filters
Showing results (141-150 of 255) with videos related to
Page
of 26
Sort By:
American Journal of Clinical Pathology
|
November 14, 2025
Hepatocellular adenomas with high-risk molecular alterations undetected by "high-risk" β-catenin and/or glutamine synthetase staining patterns
Hailey L Gosnell, Daniel E Roberts, Xuefeng Zhang, et al.
Annals of Surgical Oncology
|
June 26, 2026
The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic Cholangiocarcinoma
Yawen Dong, David Pereyra, Vanja Podrascanin, et al.
Scientific Reports
|
March 18, 2017
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
Timothy A Dinh, Eva C M Vitucci, Eliane Wauthier, et al.
Gastrointestinal Endoscopy
|
April 19, 2015
Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential
Ferga C Gleeson, Benjamin R Kipp, Jesse S Voss, et al.
In Vivo (Athens, Greece)
|
August 31, 2023
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
Jennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.
Human Pathology
|
July 23, 2021
Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma
Kwun Wah Wen, Nancy M Joseph, Amitabh Srivastava, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 14, 2024
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma
Emilien J Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Cancers
|
October 27, 2022
Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27
Xiwei Ding, Kais Zakharia, Catherine D Moser, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma
Emilien Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Annals of Surgical Oncology
|
July 4, 2026
ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic Cholangiocarcinoma
Yawen Dong, David Pereyra, Vanja Podrascanin, et al.
Page
of 26
Search research articles
Search
Showing results (141-150 of 255) with videos related to
Sort By:
Page
of 26
American Journal of Clinical Pathology
|
November 14, 2025
Hepatocellular adenomas with high-risk molecular alterations undetected by "high-risk" β-catenin and/or glutamine synthetase staining patterns
Hailey L Gosnell, Daniel E Roberts, Xuefeng Zhang, et al.
Annals of Surgical Oncology
|
June 26, 2026
The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic Cholangiocarcinoma
Yawen Dong, David Pereyra, Vanja Podrascanin, et al.
Scientific Reports
|
March 18, 2017
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
Timothy A Dinh, Eva C M Vitucci, Eliane Wauthier, et al.
Gastrointestinal Endoscopy
|
April 19, 2015
Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential
Ferga C Gleeson, Benjamin R Kipp, Jesse S Voss, et al.
In Vivo (Athens, Greece)
|
August 31, 2023
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
Jennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.
Human Pathology
|
July 23, 2021
Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma
Kwun Wah Wen, Nancy M Joseph, Amitabh Srivastava, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 14, 2024
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma
Emilien J Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Cancers
|
October 27, 2022
Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27
Xiwei Ding, Kais Zakharia, Catherine D Moser, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma
Emilien Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Annals of Surgical Oncology
|
July 4, 2026
ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic Cholangiocarcinoma
Yawen Dong, David Pereyra, Vanja Podrascanin, et al.
Page
of 26